Prodia Holds CEO Meeting 2025, Encourages Strengthening of the National Next-Generation Healthcare Ecosystem Through Automation, Robotics, and Regenerative Medicine Technology

Jakarta, November 20, 2025 - PT Prodia Widyahusada Tbk (PRDA) held the Prodia CEO Meeting 2025 with the theme "Shaping Next-Gen Care: Automation, Robotics, and Regenerative Medicine," discussing how technology can strengthen the healthcare ecosystem in Indonesia with precision, personalization, and efficiency. The event, held at the Financial Hall, Sudirman, Jakarta, was attended by executives and C-Level leaders from various industries, healthcare experts, and Prodia's Board of Commissioners and Directors.

The event was opened by Dewi Muliaty, President Director of Prodia, who delivered a keynote speech on sustainable transformation and the use of technology to bring next-generation healthcare to the community. This session was followed by presentations by Virginia Chan, Head of Digitalization and Automation for ASEAN - Siemens Healthineers, Erwin Widjaja, Senior Principal of IQVIA Indonesia, and Ari Jahja, Head of Research Indonesia at Macquarie Capital, on the role of AI in healthcare, the dynamics of the national healthcare ecosystem, and Indonesia's market potential in 2026.

In line with the theme of Next-Gen Care, Prodia continues to deliver tangible innovations, from laboratory automation technology since 2019, a 30% investment in PT Proda Stemcell Indonesia (ProSTEM) for the development of regenerative therapies, to the AI-based U by Prodia application as a "Health & Wellness Personal Assistant." These steps strengthen the national healthcare ecosystem and affirm Prodia's position as a pioneer in independent and sustainable next-generation healthcare.

For more information, contact Prodia at 1500 830, email info@prodia.co.id, or through other Prodia customer channels.

#Prodia #CEOMeeting #NextGeneration #Technology